Charles River Acquires Vigene Biosciences This acquisition will provide clients access to a comprehensive cell and gene therapy solution, including CDMO capabilities for viral vectors and plasmid DNA. learn more Research Models & Services Discovery Services Safety Assessment Laboratory Sciences Biologics Testing Solutions QC Microbial Solutions molecule type Cell and Gene Therapy Services and Products Cell and gene therapies are highly complex and the regulatory demands can be overwhelming. We can help you anticipate shifting regulations, accelerate your program, and reach key milestones. Learn More featured resource Cell and Gene Therapy Development Video Series Featured Resource Tailored Preclinical Support for Your Cell & Gene Therapies Digital Resources Insights Featured Story Albumedix Collaborates with Cobra Biologics Learn More blog E37: Ambassadors of Science Learn More Featured Story Sourcing Renewable Electricity Learn More blog FAQ: COVID Vaccines Learn More View All
molecule type Cell and Gene Therapy Services and Products Cell and gene therapies are highly complex and the regulatory demands can be overwhelming. We can help you anticipate shifting regulations, accelerate your program, and reach key milestones. Learn More
